Clinical Trial Update: Effect of the Chromium Nicotinate on Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating chromium nicotinate for Type 2 diabetes; the current status of the study is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Chromium nicotinate (Chromium(III) nicotinate)

Snippet

Sponsor: Universidade Federal de Goias | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN